Table: begin end state 1 20 cytoplasmic 21 39 transmembrane 40 52 non-cytoplasmic 53 72 transmembrane 73 77 cytoplasmic 78 96 transmembrane 97 101 non-cytoplasmic 102 121 transmembrane 122 145 cytoplasmic 146 165 transmembrane 166 172 non-cytoplasmic 173 194 transmembrane 195 200 cytoplasmic 201 217 transmembrane 218 222 non-cytoplasmic 223 247 transmembrane 248 253 cytoplasmic 254 274 transmembrane 275 320 non-cytoplasmic 321 340 transmembrane 341 373 cytoplasmic 374 393 transmembrane 394 408 non-cytoplasmic 409 434 transmembrane 435 445 cytoplasmic 446 462 transmembrane 463 505 non-cytoplasmic
Input: >AZOBR_RS08240 FitnessBrowser__azobra:AZOBR_RS08240 MTAISMSSPRAIAWPSILKEAAMTAFVALLLTIPLVGLRTVDRPTGLGLETRWNEVAAAV GLVFLGRLGLCLIREGHAVTVLVLAAAATAAGFFIAMPTEALRVILIAGGAVIAIRAVLA IRTGRSKLSQAERDKRMDHIAAQVQHASRWLGPIAVVVALAFPFTPLADRQLLDIGILLL TYIMLGWGLNIVVGLAGLLDLGYVAFYAVGAYSYALLAHYFGFSFWVCLPLAGFLAAMSG VLLGFPVLRLRGDYFAIVTLGFGEIIRIILINWYQFTGGPNGISGIPRPSFFGIADFTRT PAEGTAAFHEMFGLEFSPLHRIIFLYYLILVLALVVNLFTMRVRKLPLGRAWEALREDDI ACASLGINRTNMKLAAFAIAAMFGGFAGSFFATRQGFISPESFTFIESAIILAIVVLGGM GSQIGVVVAAFLVIGLPEAFRELADYRMLAFGMGMVLIMLWRPRGLLAHRDPTILLHGRP KGGAGGPAAGSAAAGGQGIAGGSAK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server